Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the acf domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/evogene/biomicamed.com/wp-includes/functions.php on line 6121
4th Microbiome Movement - Drug Development Summit Europe 2020 - Biomica

4th Microbiome Movement – Drug Development Summit Europe 2020

  • February 4, 2020 - February 6, 2020
  • London, UK

Join us:

Biomica is delighted to participate at 4th Microbiome Movement – Drug Development Summit Europe 2020.

Dr. Elran Haber, Biomica’s Chief Executive Officer, will provide an overview of the Company’s work developing live bio-therapeutics using PRISM, a high-resolution microbiome analysis platform and a detailed functional genomic analysis; and participate in a panel discussion on current innovation & Future Integration of Microbiome-Based Approaches into Routine Oncology Practice.

Dr. Haber will be available to participate in one-on-one meetings.

More Details and Registration: https://microbiome-europe.com/

Back to all News

Highlighted News About Biomica

Microbiome Times Partnering Forum
Mar 17, 2025

Microbiome Times Partnering Forum

Biomica’s CEO, Dr. Elran Haber, is heading to Brussels this week for the Microbiome Times Partnering Forum – a key event for advancing microbiome-based therapeutics through strategic partnerships. More info & registration: www.microbiomeforum.com

Read More
Feb 27, 2025

MIXiii Health-Tech.IL 2025

Dr. Elran Haber, Biomica’s CEO, will attend MIXiii Health-Tech.IL 2025 on March 4-5 at ICC Jerusalem. This leading Israeli health-tech conference unites industry leaders, startups, and investors to explore innovations in personalized medicine, AI-driven drug development, cancer treatment, and more. More info & registration: www.mixiii.com

Read More